Literature DB >> 25675527

Propagation of aggregated p53: Cross-reaction and coaggregation vs. seeding.

GuoZhen Wang1, Alan R Fersht2.   

Abstract

Destabilized mutant p53s coaggregate with WT p53, p63, and p73 in cancer cell lines. We found that stoichiometric amounts of aggregation-prone mutants induced only small amounts of WT p53 to coaggregate, and preformed aggregates did not significantly seed the aggregation of bulk protein. Similarly, p53 mutants trapped only small amounts of p63 and p73 into their p53 aggregates. Tetrameric full-length protein aggregated at similar rates and kinetics to isolated core domains, but there was some induced aggregation of WT by mutants in hetero-tetramers. p53 aggregation thus differs from the usual formation of amyloid fibril or prion aggregates where tiny amounts of preformed aggregate rapidly seed further aggregation. The proposed aggregation mechanism of p53 of rate-determining sequential unfolding and combination of two molecules accounts for the difference. A molecule of fast-unfolding mutant preferentially reacts with another molecule of mutant and only occasionally traps a slower unfolding WT molecule. The mutant population rapidly self-aggregates before much WT protein is depleted. Subsequently, WT protein self-aggregates at its normal rate. However, the continual production of mutant p53 in a cancer cell would gradually trap more and more WT and other proteins, accounting for the observations of coaggregates in vivo. The mechanism corresponds more to trapping by cross-reaction and coaggregation rather than classical seeding and growth.

Entities:  

Keywords:  amyloid; cancer; folding; misfolding; protein

Mesh:

Substances:

Year:  2015        PMID: 25675527      PMCID: PMC4345553          DOI: 10.1073/pnas.1500262112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Structural evolution of p53, p63, and p73: implication for heterotetramer formation.

Authors:  Andreas C Joerger; Sridharan Rajagopalan; Eviatar Natan; Dmitry B Veprintsev; Carol V Robinson; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-07       Impact factor: 11.205

2.  Gain of function of mutant p53 by coaggregation with multiple tumor suppressors.

Authors:  Jie Xu; Joke Reumers; José R Couceiro; Frederik De Smet; Rodrigo Gallardo; Stanislav Rudyak; Ann Cornelis; Jef Rozenski; Aleksandra Zwolinska; Jean-Christophe Marine; Diether Lambrechts; Young-Ah Suh; Frederic Rousseau; Joost Schymkowitz
Journal:  Nat Chem Biol       Date:  2011-03-27       Impact factor: 15.040

3.  Ultraslow oligomerization equilibria of p53 and its implications.

Authors:  Eviatar Natan; Daniel Hirschberg; Nina Morgner; Carol V Robinson; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-10       Impact factor: 11.205

Review 4.  Are interactions with p63 and p73 involved in mutant p53 gain of oncogenic function?

Authors:  Y Li; C Prives
Journal:  Oncogene       Date:  2007-04-02       Impact factor: 9.867

5.  Assessing the contribution of heterogeneous distributions of oligomers to aggregation mechanisms of polyglutamine peptides.

Authors:  Andreas Vitalis; Rohit V Pappu
Journal:  Biophys Chem       Date:  2011-04-12       Impact factor: 2.352

6.  Prion detection by an amyloid seeding assay.

Authors:  David W Colby; Qiang Zhang; Shuyi Wang; Darlene Groth; Giuseppe Legname; Detlev Riesner; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-20       Impact factor: 11.205

7.  Targeted rescue of a destabilized mutant of p53 by an in silico screened drug.

Authors:  Frank M Boeckler; Andreas C Joerger; Gaurav Jaggi; Trevor J Rutherford; Dmitry B Veprintsev; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-23       Impact factor: 11.205

8.  Effects of common cancer mutations on stability and DNA binding of full-length p53 compared with isolated core domains.

Authors:  Hwee Ching Ang; Andreas C Joerger; Sebastian Mayer; Alan R Fersht
Journal:  J Biol Chem       Date:  2006-06-05       Impact factor: 5.157

9.  Single-Molecule characterization of oligomerization kinetics and equilibria of the tumor suppressor p53.

Authors:  Sridharan Rajagopalan; Fang Huang; Alan R Fersht
Journal:  Nucleic Acids Res       Date:  2010-11-18       Impact factor: 16.971

10.  Interaction of the p53 DNA-binding domain with its n-terminal extension modulates the stability of the p53 tetramer.

Authors:  Eviatar Natan; Cetin Baloglu; Kevin Pagel; Stefan M V Freund; Nina Morgner; Carol V Robinson; Alan R Fersht; Andreas C Joerger
Journal:  J Mol Biol       Date:  2011-03-30       Impact factor: 5.469

View more
  27 in total

1.  The Yeast Prion [SWI(+)] Abolishes Multicellular Growth by Triggering Conformational Changes of Multiple Regulators Required for Flocculin Gene Expression.

Authors:  Zhiqiang Du; Ying Zhang; Liming Li
Journal:  Cell Rep       Date:  2015-12-17       Impact factor: 9.423

2.  Evidence of a Prion-Like Transmission of p53 Amyloid in Saccharomyces cerevisiae.

Authors:  Shinjinee Sengupta; Samir K Maji; Santanu K Ghosh
Journal:  Mol Cell Biol       Date:  2017-08-28       Impact factor: 4.272

3.  Self-aggregation and coaggregation of the p53 core fragment with its aggregation gatekeeper variant.

Authors:  Jiangtao Lei; Ruxi Qi; Guanghong Wei; Ruth Nussinov; Buyong Ma
Journal:  Phys Chem Chem Phys       Date:  2016-03-21       Impact factor: 3.676

4.  Heterotypic Amyloid β interactions facilitate amyloid assembly and modify amyloid structure.

Authors:  Katerina Konstantoulea; Patricia Guerreiro; Meine Ramakers; Nikolaos Louros; Liam D Aubrey; Bert Houben; Emiel Michiels; Matthias De Vleeschouwer; Yulia Lampi; Luís F Ribeiro; Joris de Wit; Wei-Feng Xue; Joost Schymkowitz; Frederic Rousseau
Journal:  EMBO J       Date:  2021-11-29       Impact factor: 11.598

Review 5.  Potential of rescue and reactivation of tumor suppressor p53 for cancer therapy.

Authors:  Emi Hibino; Hidekazu Hiroaki
Journal:  Biophys Rev       Date:  2022-01-11

Review 6.  A role for bioinorganic chemistry in the reactivation of mutant p53 in cancer.

Authors:  Jessica J Miller; Kalvin Kwan; Christian Gaiddon; Tim Storr
Journal:  J Biol Inorg Chem       Date:  2022-04-30       Impact factor: 3.862

7.  Intrinsic aggregation propensity of the p63 and p73 TI domains correlates with p53R175H interaction and suggests further significance of aggregation events in the p53 family.

Authors:  Sebastian Kehrloesser; Christian Osterburg; Marcel Tuppi; Birgit Schäfer; Karen Heather Vousden; Volker Dötsch
Journal:  Cell Death Differ       Date:  2016-07-22       Impact factor: 15.828

Review 8.  Aggregation and Prion-Like Properties of Misfolded Tumor Suppressors: Is Cancer a Prion Disease?

Authors:  Danielly C F Costa; Guilherme A P de Oliveira; Elio A Cino; Iaci N Soares; Luciana P Rangel; Jerson L Silva
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-10-03       Impact factor: 10.005

Review 9.  The "Jekyll and Hyde" Actions of Nucleic Acids on the Prion-like Aggregation of Proteins.

Authors:  Jerson L Silva; Yraima Cordeiro
Journal:  J Biol Chem       Date:  2016-06-10       Impact factor: 5.157

10.  Multisite aggregation of p53 and implications for drug rescue.

Authors:  GuoZhen Wang; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.